Regeneron Pharmaceuticals | 营业利润



Operating Profit 更改 日
AbbVie USD 3.73B 5.22B 2025-03
Agios Pharmaceuticals USD -125037000 1.11B 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amgen USD 2.31B 182M 2024-12
Astellas Pharma JPY 63.52B 179.71B 2025-03
AstraZeneca USD 2.04B 731M 2024-12
Biogen USD 441.4M 24.4M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Eli Lilly USD 5.15B 3.62B 2024-12
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 696M 507M 2024-12
Incyte USD 301.51M 155.43M 2024-12
Ionis Pharmaceuticals USD -110823000 37.83M 2024-12
J&J USD 13.63B 9.74B 2025-03
Kyowa Hakko Kirin JPY 26.93B 2.53B 2024-09
Merck USD 5.87B 1.57B 2025-03
Moderna USD -1246000000 1.18B 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Novartis USD 3.4B 193M 2024-12
Pfizer USD -409000000 5.57B 2024-12
Regeneron Pharmaceuticals USD 990.2M 189.3M 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 861M 2.77B 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Teva Pharmaceutical Industries USD 455M 506M 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
United Therapeutics USD 357.7M 14.6M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



Regeneron Pharmaceuticals 营业利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2025.